Skip Nav Destination
Close Modal
Update search
NARROW
Format
Journal
Date
Availability
1-2 of 2
Edwin van Dellen
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Publisher: Journals Gateway
Network Neuroscience (2022) 6 (2): 339–356.
Published: 01 June 2022
FIGURES
| View All (5)
Abstract
View article
PDF
Multiple sclerosis (MS) features extensive connectivity changes, but how structural and functional connectivity relate, and whether this relation could be a useful biomarker for cognitive impairment in MS is unclear. This study included 79 MS patients and 40 healthy controls (HCs). Patients were classified as cognitively impaired (CI) or cognitively preserved (CP). Structural connectivity was determined using diffusion MRI and functional connectivity using resting-state magnetoencephalography (MEG) data (theta, alpha1, and alpha2 bands). Structure-function coupling was assessed by correlating modalities, and further explored in frequency bands that significantly correlated with whole-brain structural connectivity. Functional correlates of short- and long-range structural connections (based on tract length) were then specifically assessed. Receiving operating curve analyses were performed on coupling values to identify biomarker potential. Only the theta band showed significant correlations between whole-brain structural and functional connectivity (rho = −0.26, p = 0.023, only in MS). Long-range structure-function coupling was stronger in CI patients compared to HCs ( p = 0.005). Short-range coupling showed no group differences. Structure-function coupling was not a significant classifier of cognitive impairment for any tract length (short-range area under the curve (AUC) = 0.498, p = 0.976, long-range AUC = 0.611, p = 0.095). Long-range structure-function coupling was stronger in CI MS compared to HCs, but more research is needed to further explore this measure as biomarkers in MS. Author Summary Cognitive impairment in multiple sclerosis (MS) is common and relates to structural and functional connectivity. However, it remains unclear whether the interplay (coupling) between structural and functional connectivity could be a biomarker of MS-related cognitive impairment. This study investigated the cognitive relevance of structure-function coupling in 79 MS patients and 40 healthy controls using diffusion MRI and magnetoencephalography. Results show that coupling was stronger in cognitively impaired MS patients compared to controls, but only when considering long-distance connections. Nonetheless, classifier analyses indicated only weak biomarker potential in terms of sensitivity and specificity. Future studies should include additional operationalization of coupling as well as longitudinal and regional or network level data.
Journal Articles
Publisher: Journals Gateway
Network Neuroscience (2019) 3 (4): 969–993.
Published: 01 September 2019
FIGURES
Abstract
View article
PDF
Clinical network neuroscience, the study of brain network topology in neurological and psychiatric diseases, has become a mainstay field within clinical neuroscience. Being a multidisciplinary group of clinical network neuroscience experts based in The Netherlands, we often discuss the current state of the art and possible avenues for future investigations. These discussions revolve around questions like “How do dynamic processes alter the underlying structural network?” and “Can we use network neuroscience for disease classification?” This opinion paper is an incomplete overview of these discussions and expands on ten questions that may potentially advance the field. By no means intended as a review of the current state of the field, it is instead meant as a conversation starter and source of inspiration to others.